Učitavanje...
Bronchodilator efficacy of extrafine glycopyrronium bromide: the Glyco 2 study
An extrafine formulation of the long-acting muscarinic antagonist glycopyrronium bromide (GB) is in development for chronic obstructive pulmonary disease (COPD), in combination with beclometasone dipropionate and formoterol fumarate – a “fixed triple”. This two-part study was randomized, double blin...
Spremljeno u:
| Izdano u: | Int J Chron Obstruct Pulmon Dis |
|---|---|
| Glavni autori: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5511020/ https://ncbi.nlm.nih.gov/pubmed/28744115 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S137659 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|